Kelleher Financial Advisors’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-131,257
Closed -$3.24M 134
2016
Q4
$3.24M Sell
131,257
-3,431
-3% -$76.9K 1.8% 15
2016
Q3
$2.67M Sell
134,688
-150
-0.1% -$2.78K 1.51% 26
2016
Q2
$1.85M Hold
134,838
1.12% 31
2016
Q1
$1.85M Hold
134,838
1.02% 32
2015
Q4
$1.37M Hold
134,838
0.93% 35
2015
Q3
$1.35M Sell
134,838
-1,000
-0.7% -$11.7K 0.9% 39
2015
Q2
$2.01M Sell
135,838
-500
-0.4% -$7.79K 1.15% 34
2015
Q1
$2.26M Sell
136,338
-2,687
-2% -$41.9K 1.25% 29
2014
Q4
$2.11M Sell
139,025
-2,500
-2% -$36.3K 1.13% 30
2014
Q3
$2.03M Buy
141,525
+1,000
+0.7% +$14.2K 1.1% 32
2014
Q2
$1.99M Sell
140,525
-1,000
-0.7% -$15.2K 1.04% 31
2014
Q1
$2.42M Sell
141,525
-1,100
-0.8% -$18.2K 1.32% 27
2013
Q4
$2.1M Sell
142,625
-15,000
-10% -$206K 1.08% 33
2013
Q3
$2.09M Hold
157,625
1.19% 30
2013
Q2
$1.69M Buy
+157,625
New +$1.77M 1.03% 33

Other funds holding PMD

Kelleher Financial Advisors's PMD Position: Q1 2017 in Review

Kelleher Financial Advisors sold out of Psychemedics Corporation (PMD) in Q1 2017, closing a stake of 131,257 shares — an estimated $3.24M sold.

Kelleher Financial Advisors first reported a position in PMD in Q2 2013 and held it in 15 quarters. The position peaked at $3.24M in Q4 2016. 53 funds tracked by Wall St. Rank hold PMD as of Q1 2017.

  • Kelleher Financial Advisors reported no remaining Psychemedics Corporation position as of Q1 2017 after selling out during the quarter.
  • Kelleher Financial Advisors sold 131,257 Psychemedics Corporation shares in Q1 2017, an estimated $3.24M.
  • Kelleher Financial Advisors first reported a position in Psychemedics Corporation in Q2 2013 and held it in 15 quarters.
  • Kelleher Financial Advisors's Psychemedics Corporation position peaked at $3.24M in Q4 2016.
  • 53 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2017.

Based on Kelleher Financial Advisors's 13F filing for Q1 2017, filed 12 May 2017.